Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,365,632
-
Total 13F shares
-
36,350,736
-
Share change
-
+639,872
-
Total reported value
-
$617,991,392
-
Price per share
-
$16.98
-
Number of holders
-
99
-
Value change
-
-$10,766,108
-
Number of buys
-
56
-
Number of sells
-
32
Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q1 2022
As of 31 Mar 2022,
Replimune Group, Inc. - COMMON STOCK (REPL) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,350,736 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Omega Fund Management, LLC, Redmile Group, LLC, Atlas Venture Life Science Advisors, LLC, STATE STREET CORP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, EMERALD ADVISERS, LLC, FMR LLC, and EMERALD MUTUAL FUND ADVISERS TRUST.
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.